'"Giving sickle cell patients a more direct pathway into the medical cannabis program will permit them a non-opioid option to manage their pain,” said Commissioner of Health Jan Malcolm.
Minnesota’s medical cannabis program already has Tourette’s syndrome as one of its qualifying medical conditions. Vocal or motor tic disorder is distinct from Tourette’s syndrome in that patients experience only vocal or motor tics, where people with Tourette’s experience both vocal and motor tics.
Evidence from Tourette’s patients who participate in the program shows that medical cannabis can effectively treat tics. “This change will allow people who have either vocal or motor tics to participate in Minnesota’s medical cannabis program,” she said.'
https://www.health.state.mn.us/news/pressrel/2020/cannabis120120.html
A team of investigators affiliated with Yale University in Connecticut and the Sackler School of Medicine in Israel assessed the relationship between cannabis use and hospitalization rates in patients with SCD over a six-month period.
They reported, “The patients who obtained medical marijuana showed a reduction in median six-month hospital admissions compared with the patients who … did not obtain medical marijuana.”'
https://norml.org/news/2020/08/20/study-medical-cannabis-use-associated-with-fewer-hospitalizations-among-patients-with-sickle-cell-disease
'"Patients with sickle cell disease and chronic pain have no real alternative to chronic opioid therapy, which has severe limitations and disadvantages," said Laura DeCastro, MD, MBBS and Pitt associate professor of medicine, director of benign hematology for the Institute for Transfusion Medicine and UPMC Hillman Cancer Center, and director of Clinical Translational Research for the Sickle Cell Disease Research Center of Excellence. "We are proud to have this opportunity to study potential cannabis treatments for these patients who live in constant debilitating pain."
"Our partnership with the University of Pittsburgh aligns with our mission of promoting well-being for all and to provide access and treatment options to communities who need it most," said Wrigley. "SCD is a devastating disease that has impacted many African American families, both medically and financially, and we are hopeful that our research partnership with Pitt will help to improve outcomes through cannabis."'
https://www.prnewswire.com/news-releases/university-of-pittsburgh-and-parallel-a-leading-cannabis-company-join-forces-in-pennsylvania-medical-marijuana-research-program-301106823.html
'Investigators with the Yale School of Medicine and the Medical College of Wisconsin assessed hospitalization rates among SCD patients with and without a history of cannabis use.
They reported that SCD patients who used cannabis daily had "1.8 fewer annual [hospital] admissions and 1.2 fewer emergency room (ER) visits" as compared to non-users.
Authors concluded, "We show that people with SCD with more severe pain crisis are more likely to use daily cannabis, yet have lower rates of hospital admission and ER use as compared with others with similar disease severity and pain impact."'
https://norml.org/news/2020/02/27/study-sickle-cell-disease-patients-who-use-cannabis-less-likely-to-require-hospitalization
The 21 qualifying conditions for medical marijuana in Ohio - AIDS, HIV-positive status, amyotrophic lateral sclerosis, Alzheimer's disease, cancer, chronic traumatic encephalopathy, inflammatory bowel disease, Crohn's disease, ulcerative colitis, epilepsy or another brain-seizure disorder, fibromyalgia, glaucoma, hepatitis C, multiple sclerosis, chronic/severe/intractable pain, Parkinson's disease, post-traumatic stress disorder, sickle cell disease, spinal cord disease or injury, Tourette syndrome, traumatic brain injury
'The Enquirer set out to determine how many Ohioans could be eligible for medical marijuana under the 21 qualifying conditions from the Ohio Department of Health, the U.S. Centers for Disease Control and Prevention and private nonprofits that raise money for medical research. For many diseases, the numbers of patients are estimates, since the government does not track patient counts for every ailment. The conclusion: About 3.5 million Ohioans deal with at least one of the qualifying conditions. Ohio's population is 11.66 million'
https://www.cincinnati.com/story/news/2018/07/18/3-10-ohioans-eligible-medical-marijuana-card/784017002/
Intractable epilepsy, Seizure disorders, Severe nausea, Severe or chronic pain, Cachexia (wasting syndrome), Anorexia, hospice or palliative care, Terminal illness, Sickle cell anemia, Post-traumatic stress disorder (PTSD), Crohn’s disease, Huntington’s disease, Neuropathies, Damage to the nervous tissue of the spinal cord, Multiple sclerosis, Parkinson’s disease, Amyotrophic lateral sclerosis/Lou Gehrig’s disease, HIV/AIDS, Cancer, Traumatic brain injury (TBI), Chronic renal failure requiring dialysis, Spasticity, Muscle Spasms, Cramping, Appetite loss, Severe Vomiting, Hepatitis C, Glaucoma, Pain lasting longer than two weeks, Autism, Ulcerative colitis, Alzheimer’s disease, Neural-tube defects, Idiopathic Pulmonary Fibrosis, Neurodegenerative diseases, Dyskinetic and spastic movement disorders, Inflammatory bowel disease (IBD), Tourette’s syndrome, Fibromyalgia, Arthritis, Lupus, Diabetes, Obstructive sleep apnea, Spasmodic Torticollis (cervical dystonia), Inclusion Body Myositis, Anxiety, Migraines, Muscular dystrophy, Chronic pancreatitis, Ehler’s Danlos Syndrome, Nail-patella syndrome, Lennox-Gestaut syndrome, Dravet syndrome, Spinocerebellar ataxia, Syringomyelia, Tarlov cysts, Sjogren’s syndrome, Post-concussion syndrome, Neurofibromatosis, Myasthenia gravis, Myoclonus, Hydrocephalus, Hydromyelia, Interstitial cystitis, CRPS (Complex Regional Pain Syndrome Type II), Dystonia, Fibrous dysplasia, Causalgia, Chronic inflammatory demyelinating polyneuropathy, Arnold-Chiari malformation, Epidermolysis bullosa, Mitochondrial disease, Decompensated cirrhosis, Osteogenesis Imperfecta, Cerebral palsy, Cystic fibrosis, Post Herpetic Neuralgia, Post Laminectomy Syndrome with Chronic Radiculopathy, Severe Psoriasis and Psoriatic Arthritis...
Source: https://www.leafly.com/news/health/qualifying-conditions-for-medical-marijuana-by-state
Pennsylvania's list of medical conditions qualifying for medical marijuana - amyotrophic lateral sclerosis, autism, cancer- including remission therapy, Crohn's disease, damage to the nervous tissue of the central nervous system (brain-spinal cord) with objective neurological indication of intractable spasticity and other associated neuropathies, dyskinetic and spastic movement disorders, epilepsy, glaucoma, HIV/AIDS, Huntington's disease, inflammatory bowel disease, intractable seizures, multiple sclerosis, neurodegenerative diseases, neuropathies, Opioid use disorder for which conventional therapeutic interventions are contraindicated or ineffective or for which adjunctive therapy is indicated in combination with primary therapeutic interventions, Parkinson's disease, post-traumatic stress disorder, severe chronic or intractable pain of neuropathic origin or severe chronic or intractable pain, sickle cell anemia, terminal illness.
'In particular, I would really love to see anxiety, depression and ADHD added,” Spaar said.'
https://triblive.com/state/pennsylvania/14367032-74/pennsylvania-to-consider-more-conditions-that-should-qualify-for-medical-marijuana
No comments:
Post a Comment